相似文献
1
Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides.
Nucleic Acids Res. 2003 Jul 15;31(14):4109-18. doi: 10.1093/nar/gkg439.
2
Oligodeoxyribonucleotide analogs functionalized with phosphonoacetate and thiophosphonoacetate diesters.
Curr Protoc Nucleic Acid Chem. 2004 Oct;Chapter 4:Unit 4.24. doi: 10.1002/0471142700.nc0424s18.
3
Solid-phase chemical synthesis of phosphonoacetate and thiophosphonoacetate oligodeoxynucleotides.
J Am Chem Soc. 2003 Jan 29;125(4):940-50. doi: 10.1021/ja027983f.
4
Biochemical and physicochemical properties of phosphorodithioate DNA.
Biochemistry. 1996 Jul 2;35(26):8734-41. doi: 10.1021/bi960318x.
5
Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.
Nucleic Acids Res. 1997 Jan 15;25(2):370-8. doi: 10.1093/nar/25.2.370.
6
Investigation of some properties of oligodeoxynucleotides containing 4'-thio-2'-deoxynucleotides: duplex hybridization and nuclease sensitivity.
Nucleic Acids Res. 1996 Nov 1;24(21):4117-22. doi: 10.1093/nar/24.21.4117.
7
Synthesis and biological activity of phosphonoacetate- and thiophosphonoacetate-modified 2'-O-methyl oligoribonucleotides.
Org Biomol Chem. 2012 Jan 28;10(4):746-54. doi: 10.1039/c1ob06614e. Epub 2011 Nov 29.
8
Ketone-DNA: a versatile postsynthetic DNA decoration platform.
Org Lett. 2001 Dec 13;3(25):3983-6. doi: 10.1021/ol016626r.
9
Synthesis and biological activity of phosphonocarboxylate DNA.
Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):539-46. doi: 10.1080/15257770701489896.
10
Oligodeoxynucleotide analogs as informational drugs to regulate translation.
Nucleic Acids Symp Ser. 1991(24):139-42.
引用本文的文献
1
Chemical Modifications in Nucleic Acid Therapeutics.
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation.
Biomolecules. 2025 Jul 4;15(7):965. doi: 10.3390/biom15070965.
3
Chemical engineering of CRISPR-Cas systems for therapeutic application.
Nat Rev Drug Discov. 2025 Mar;24(3):209-230. doi: 10.1038/s41573-024-01086-0. Epub 2024 Dec 17.
4
A Visual Compendium of Principal Modifications within the Nucleic Acid Sugar Phosphate Backbone.
Molecules. 2024 Jun 26;29(13):3025. doi: 10.3390/molecules29133025.
5
Synthesis and Properties of Oligonucleotides Containing LNA-Sulfamate and Sulfamide Backbone Linkages.
Org Lett. 2024 May 17;26(19):4137-4141. doi: 10.1021/acs.orglett.4c01232. Epub 2024 May 8.
6
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.
BioDrugs. 2024 Mar;38(2):177-203. doi: 10.1007/s40259-024-00644-7. Epub 2024 Jan 22.
7
Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides.
RSC Chem Biol. 2022 May 16;3(6):765-772. doi: 10.1039/d2cb00100d. eCollection 2022 Jun 8.
8
A New 1,5-Disubstituted Triazole DNA Backbone Mimic with Enhanced Polymerase Compatibility.
J Am Chem Soc. 2021 Oct 6;143(39):16293-16301. doi: 10.1021/jacs.1c08057. Epub 2021 Sep 21.
9
Modified internucleoside linkages for nuclease-resistant oligonucleotides.
RSC Chem Biol. 2020 Dec 8;2(1):94-150. doi: 10.1039/d0cb00136h. eCollection 2021 Feb 1.
10
MicroRNAs Regulating Autophagy in Neurodegeneration.
Adv Exp Med Biol. 2021;1208:191-264. doi: 10.1007/978-981-16-2830-6_11.
本文引用的文献
1
Solid-phase chemical synthesis of phosphonoacetate and thiophosphonoacetate oligodeoxynucleotides.
J Am Chem Soc. 2003 Jan 29;125(4):940-50. doi: 10.1021/ja027983f.
2
RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA).
Nucleic Acids Res. 2001 Dec 15;29(24):4941-7. doi: 10.1093/nar/29.24.4941.
3
Prooligonucleotides exhibit less serum-protein binding than phosphodiester and phosphorothioate oligonucleotides.
Nucleosides Nucleotides Nucleic Acids. 2000 May-Jun;19(5-6):995-1003. doi: 10.1080/15257770008033038.
4
Molecular mechanisms of action of antisense drugs.
Biochim Biophys Acta. 1999 Dec 10;1489(1):31-44. doi: 10.1016/s0167-4781(99)00148-7.
5
Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?
Antisense Nucleic Acid Drug Dev. 2000 Apr;10(2):117-21. doi: 10.1089/oli.1.2000.10.117.
6
Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells.
Nucleic Acids Res. 1999 Oct 15;27(20):4071-6. doi: 10.1093/nar/27.20.4071.
7
First synthesis of alternating SATE-phosphotriester/phosphodiester prooligonucleotides on solid support.
Bioorg Med Chem Lett. 1998 Oct 20;8(20):2913-8. doi: 10.1016/s0960-894x(98)00518-6.
8
Modified oligonucleotides: synthesis and strategy for users.
Annu Rev Biochem. 1998;67:99-134. doi: 10.1146/annurev.biochem.67.1.99.
9
Pharmacokinetics of oligonucleotides.
Ciba Found Symp. 1997;209:60-75; discussion 75-8. doi: 10.1002/9780470515396.ch6.
10
The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.
J Biol Chem. 1997 Jul 18;272(29):18191-9. doi: 10.1074/jbc.272.29.18191.
Zotero 插件